I believe that the recent description by Goodship et al' of discordance in monozygotic twins with a 22ql 1 deletion raises some interesting issues. The likelihood of a heart defect in a person with a constitutional 22ql 1 deletion cannot currently be estimated, as ascertainment of such patients is usually on the basis of the presence of a heart lesion. In addition, the true prevalence of 22qll deletions is not known, although a lower limit of 1:4000 has been quoted on the basis of children presenting with congenital heart defects.2 Thus, until prospective studies are carried out that allow complete ascertainment of subjects with a 22ql 1 deletion, irrespective of phenotype, this question cannot be answered. Variability of phenotypic expression among people with presumably identical deletions (that is, familial cases) strengthens the concept that a 22q1 1 deletion merely increases the likelihood of certain anomalies being present but does not guarantee them.3 It is clear, therefore, that the association of heart disease with this deletion is far from deterministic.
The discovery of monozygotic twins with a 22q1 1 deletion who are discordant for heart disease should, therefore, come as no surprise, although until this report, the role of "genetic background" could never be ignored.' While it is clearly true that the phenotype in these twins could not have been predicted on the basis of their identical (germline) genotypes, it is not necessarily true that the discordance cannot be attributed to genetic differences between the two. If, in the above paper, the words "chromosome 22ql 1 deletion" had been replaced by "germline mutation in the retinoblastoma gene", little surprise would have been expressed, and the discussion would have focused on the chance element involved in the "second hit" genetic mutations now known to be necessary for phenotypic expression in retinoblastoma.4 The concept of a "second hit" in congenital malformations, however, is not widely accepted. The (2) A second hit, either on the contralateral 22ql or elsewhere in the genome, may give rise to the relevant (uncommon) abnormality. This mechanism, as described above for the Ds gene, has been invoked to explain vertical transmission of conditions that give rise to "phenotypic mosaicism" and which had hitherto been thought of as resulting from genetic mosaicism (for example, ILVEN).'0 In this model, the presence of a germline mutation in a large number of subjects does not, of itself, result in the phenotype; in a small proportion, however, a second mutation occurring at an early stage in development will result in the relevant abnormality, which will generally appear mosaically. There will be few such subjects as the chance that the second hit will occur in the right cell type and early enough in development is very low. The majority of such subjects will therefore occur sporadically and be deemed to represent new postzygotic mutations. The discovery, however, of even one example of a parent-child combination, both displaying "phenotypic mosaicism" must force a re-evaluation of the original hypothesis. 
